ABT vs FIVE · P/E 25, rev $44.33B vs P/E 28, rev $1.39B
Abbott Laboratories (ABT) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the ABT and FIVE stock pages for the full models.
Not investment advice.